Did not become law. It stopped in the General Assembly's Financial Institutions and Insurance Committee on January 9, 2018. The 2018–2019 session has ended.
2018–2019 Session
Assembly Bill 646
Requires insurers to provide coverage for medications and dose-intensive chemotherapy/bone marrow transplants and umbilical cord blood transplants for treatment of sickle cell anemia.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the General Assembly
Sponsor from Jan 9
Chief co-sponsor from Jan 9
Its course
January 9 to January 9, 2018, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the General AssemblyJan 9 to Jan 9 · stopped0 days
Financial Institutions and InsuranceJan 9 to Jan 9 · stopped0 days
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the General Assembly Jan 9
- Jan 9Introduced in the General Assembly and sent to Financial Institutions and Insurance
All 1 actions, as published
- Jan 9INT 1RA REF AFIGeneral Assembly